(Q43906231)

27 November 2017

title

Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients (English)

1 reference

27 November 2017

1 reference

2

Shinichi Oikawa

1 reference

27 November 2017

Tazuko Nagashima

1

1 reference

27 November 2017

Yoshitake Hirayama

3

1 reference

27 November 2017

Yoshihisa Tokita

4

1 reference

27 November 2017

Akihiro Sekikawa

5

1 reference

27 November 2017

Yasushi Ishigaki

6

1 reference

27 November 2017

Rie Yamada

7

1 reference

27 November 2017

Teruo Miyazawa

8

1 reference

27 November 2017

publication date

1 April 2002

1 reference

Diabetes Research and Clinical Practice

27 November 2017

published in

1 reference

27 November 2017

volume

56

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

19-25

1 reference

Free radicals and diabetes

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Elevation of plasma lipid peroxides in non-insulin dependent diabetics with multiple lacunar infarcts.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Levels of lipid peroxidation product and glycated hemoglobin A1c in the erythrocytes of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Lipid peroxides and human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Determination of phospholipid hydroperoxides using luminol chemiluminescence--high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Inactivation of Cu,Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

O2- generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Hemoglobin A1cLevels in a Diabetes Detection Program*

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900353-9

7 January 2021

10.1016/S0168-8227(01)00353-9

Identifiers

DOI

1 reference

27 November 2017

1 reference